Carole Masurier

4.0k total citations · 2 hit papers
23 papers, 2.8k citations indexed

About

Carole Masurier is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Carole Masurier has authored 23 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 13 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Carole Masurier's work include Virus-based gene therapy research (13 papers), Immunotherapy and Immune Responses (11 papers) and RNA Interference and Gene Delivery (8 papers). Carole Masurier is often cited by papers focused on Virus-based gene therapy research (13 papers), Immunotherapy and Immune Responses (11 papers) and RNA Interference and Gene Delivery (8 papers). Carole Masurier collaborates with scholars based in France, United States and United Kingdom. Carole Masurier's co-authors include P. Véron, Sylvie Boutin, Christian Leborgne, Olivier Benvéniste, Marie Montus, Caroline Flament, Laurence Zitvogel, Anne Lozier, Joseph Wolfers and Stéphanie Pouzieux and has published in prestigious journals such as Nature Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Carole Masurier

23 papers receiving 2.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

2001 1.3k citations Joseph Wolfers, Anne Lozier et al. Nature Medicine profile →
Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors

2010 753 citations Sylvie Boutin, P. Véron et al. Human Gene Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carole Masurier France	13	2.0k	978	807	541	501	23	2.8k
Dea Nagy United States	15	2.2k 1.1×	1.9k 1.9×	327 0.4×	196 0.4×	637 1.3×	22	3.3k
Els Verhoeyen France	35	2.2k 1.1×	1.7k 1.8×	1.1k 1.3×	205 0.4×	1.4k 2.8×	114	4.1k
Patrick Nusbaum France	21	1.8k 0.9×	1.5k 1.5×	567 0.7×	115 0.2×	584 1.2×	34	2.9k
Narayanaswamy Ramesh United States	27	1.0k 0.5×	355 0.4×	1.3k 1.6×	213 0.4×	293 0.6×	44	3.1k
Gregory E. Plautz United States	29	2.4k 1.2×	1.6k 1.6×	1.6k 2.0×	130 0.2×	1.2k 2.5×	56	4.2k
Ute Modlich Germany	28	2.8k 1.4×	2.1k 2.1×	454 0.6×	166 0.3×	1.1k 2.1×	78	3.7k
Siobhan O. Burns United Kingdom	27	788 0.4×	867 0.9×	1.5k 1.9×	187 0.3×	344 0.7×	87	3.2k
Thomas C. Reynolds United States	18	2.8k 1.4×	1.8k 1.8×	573 0.7×	159 0.3×	812 1.6×	23	4.5k
E G Nabel United States	17	1.6k 0.8×	998 1.0×	428 0.5×	169 0.3×	357 0.7×	20	2.4k
Johann Meyer Germany	23	2.9k 1.4×	1.3k 1.4×	570 0.7×	139 0.3×	870 1.7×	46	4.0k

Countries citing papers authored by Carole Masurier

Since Specialization

Citations

This map shows the geographic impact of Carole Masurier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carole Masurier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carole Masurier more than expected).

Fields of papers citing papers by Carole Masurier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carole Masurier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carole Masurier. The network helps show where Carole Masurier may publish in the future.

Co-authorship network of co-authors of Carole Masurier

This figure shows the co-authorship network connecting the top 25 collaborators of Carole Masurier. A scholar is included among the top collaborators of Carole Masurier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carole Masurier. Carole Masurier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Véron, P., Christian Leborgne, Jack‐Yves Deschamps, et al.. (2020). Capsid-specific removal of circulating antibodies to adeno-associated virus vectors. Scientific Reports. 10(1). 864–864. 80 indexed citations

Gross, David‐Alexandre, Christian Leborgne, Pascal Chappert, et al.. (2019). Induction of tumor-specific CTL responses using the C-terminal fragment of Viral protein R as cell penetrating peptide. Scientific Reports. 9(1). 3937–3937. 12 indexed citations

Leborgne, Christian, Sylvie Boutin, Fanny Collaud, et al.. (2018). Prevalence and long-term monitoring of humoral immunity against adeno-associated virus in Duchenne Muscular Dystrophy patients. Cellular Immunology. 342. 103780–103780. 41 indexed citations

Véron, P., Elisa Masat, Bernard Gjata, et al.. (2015). 523. Deep Sequencing of T Cell Receptor in Peripheral Blood and Muscle from Adeno-Associated Virus Vector-Injected Subjects Reveals Differences in T Cell Clonality Between the Two Compartments. Molecular Therapy. 23. S210–S210. 1 indexed citations

Guiner, Caroline Le, Laurent Servais, Bernard Gjata, et al.. (2015). Adeno-associated virus vector (AAV) microdystrophin gene therapy prolongs survival and restores muscle function in the canine model of Duchenne muscular dystrophy (DMD). Neuromuscular Disorders. 25. S315–S315. 2 indexed citations

Véron, P., et al.. (2012). Humoral and Cellular Capsid-Specific Immune Responses to Adeno-Associated Virus Type 1 in Randomized Healthy Donors. The Journal of Immunology. 188(12). 6418–6424. 70 indexed citations

Saheb, Samir, Sylvie Boutin, Christian Leborgne, et al.. (2011). A 10 Patient Case Report on the Impact of Plasmapheresis Upon Neutralizing Factors Against Adeno-associated Virus (AAV) Types 1, 2, 6, and 8. Molecular Therapy. 19(11). 2084–2091. 163 indexed citations

Moulay, Gilles, Carole Masurier, Pascal Bigey, Daniel Scherman, & Antoine Kichler. (2010). Soluble TNF-α receptor secretion from healthy or dystrophic mice after AAV6-mediated muscle gene transfer. Gene Therapy. 17(11). 1400–1410. 5 indexed citations

Moulay, Gilles, Sylvie Boutin, Carole Masurier, Daniel Scherman, & Antoine Kichler. (2010). Polymers for Improving the In Vivo Transduction Efficiency of AAV2 Vectors. PLoS ONE. 5(12). e15576–e15576. 13 indexed citations

10.

Boutin, Sylvie, P. Véron, Christian Leborgne, et al.. (2010). Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors. Human Gene Therapy. 21(6). 704–712. 753 indexed citations breakdown →

11.

Véron, P., Sylvie Boutin, Samia Martin, et al.. (2009). Highly efficient transduction of human plasmacytoid dendritic cells without phenotypic and functional maturation. Journal of Translational Medicine. 7(1). 10–10. 18 indexed citations

12.

Masurier, Carole, Sylvie Boutin, P. Véron, et al.. (2007). Enhanced Lentiviral Transduction of Monocyte-Derived Dendritic Cells in The Presence of Conditioned Medium from Dying Monocytes. Human Gene Therapy. 18(2). 161–170. 2 indexed citations

13.

Véron, P., et al.. (2007). Major Subsets of Human Dendritic Cells Are Efficiently Transduced by Self-Complementary Adeno-Associated Virus Vectors 1 and 2. Journal of Virology. 81(10). 5385–5394. 41 indexed citations

14.

Véron, P., Sylvie Boutin, Jacky Bernard, et al.. (2006). Efficient transduction of monocyte‐ and CD34⁺‐ derived Langerhans cells with lentiviral vectors in the absence of phenotypic and functional maturation. The Journal of Gene Medicine. 8(8). 951–961. 12 indexed citations

15.

Wolfers, Joseph, Anne Lozier, Graça Raposo, et al.. (2001). Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nature Medicine. 7(3). 297–303. 1347 indexed citations breakdown →

16.

Colombo, B., Roger Lacave, Catherine Pioche‐Durieu, et al.. (2000). Cellular but not humoral immune responses generated by vaccination with dendritic cells protect mice against leukaemia. Immunology. 99(1). 8–15. 6 indexed citations

17.

Salomon, Benoı̂t L., José L. Cohen, Carole Masurier, & David Klatzmann. (1998). Three Populations of Mouse Lymph Node Dendritic Cells with Different Origins and Dynamics. The Journal of Immunology. 160(2). 708–717. 93 indexed citations

18.

Heudes, Didier, Isabelle Lamarre, Carole Masurier, et al.. (1997). Reduction of insulin and triglycerides delays glomerulosclerosis in obese Zucker rats. Kidney International. 52(6). 1532–1542. 30 indexed citations

19.

Masurier, Carole, Roger Lacave, Benoı̂t L. Salomon, et al.. (1997). The Role of Dendritic Cells in the Transport of HIV to Lymph Nodes Analysed in Mouse. Advances in experimental medicine and biology. 417. 411–414. 2 indexed citations

20.

Chevalier, Julie, et al.. (1995). [Approach of cellular mechanisms of glomerulosclerosis in a model of accelerated aging the obese Zucker rat].. PubMed. 189(6). 987–1007. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact